Certain patientssuch as those with specific types of endocrine cancersshould avoid GLP1s, he explained, and there are clear guidelines for who may benefit most, including people with diabetes, obesity or other chronic conditions that contribute to long-term weight gain
Findings from the pivotal New England Journal of Medicine trial confirmed a 4.3% reduction in BMI over 56 weeks, supporting its clinical effectiveness in this age group
A Western diet is known to increase both glycogen and fat in the liver, and, as expected, both glycogen and liver fat (triglycerides) were markedly elevated in the WD+stevia group (Figure 3AC)
Uncropped images of every blot in the manuscript are shown in Supplementary Figs
Once you begin using a vial, keep it refrigerated between doses
Monitoring for hypoglycemia is important, particularly in patients taking tirzepatide in combination with insulin or sulfonylureas